Amboss Overview
Key information, insights, contact details, and team at Amboss .
AMBOSS is a digital medical knowledge platform that provides clinical content, study resources, and tools for medical professionals and students to enhance learning and improve decision-making in healthcare.
$259.70M
Latest Funding
Venture Round
Latest Funding Stage
2025-03-25
Funding Date
859
Employees
Germany
Location
Berlin, Berlin
City & State
Open Positions
View Careers PageHiring For
Investment Thesis
No thesis information available yet.
Key Contacts
Team Members
( total contacts)Founding Story
No founding story information available yet.
Product
No product analysis information available yet.
Market
No market analysis information available yet.
Competition
No competitive analysis information available yet.
Business Model
No business model analysis information available yet.
Similar Companies
Overture Life
Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures, aiming to enhance the efficiency and accessibility of in vitro fertilization (IVF). Its solutions focus on automating complex embryology lab processes, such as egg vitrification and embryo warming, to improve consistency and reducecosts.
TadHealth
TadHealth offers a school-based EHR and health management product with essential modules for running clinics and staff health operations, enabling public sector institutions to seamlessly transition between billable processes and active resources within communities.
Araceli Biosciences
Araceli Biosciences is a developer of scientific tools for tissue- and cell-based biomarker discovery, drug discovery, and drug development. The company focuses on developing scientific instruments to improve outcomes and enable customers to advance scientific and medical research.
Grove Biopharma
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges, focused on the discovery and development of a novel class of “protein-like polymers” to treat significant unmet medical needs in chronic inflammatory and neurodegenerative diseases.
Traction
No traction analysis information available yet.
Valuation
No valuation analysis information available yet.
Key Opportunities
No key opportunities information available yet.
Key Risks
No key risks information available yet.